Shots: The approval is based on two study STICLO France and STICLO Italy assessing Diacomit vs PBO in patients with Dravet Syndrome aged 2 years of age and older taking clobazam STICLO France and STICLO Italy study results: responder rate (71%, 67% vs 5%, 9.1%) Diacomit 250mg & 500mg (stiripentol) is an anti-convulsant drug, approved […]Read More
